Central Nervous System Therapeutic Market Report

Date: 9 April 2019

The mental health has been witnessing growth at a noteworthy rate over the past few years backed by rise in stress and depression among people as well as increasing awareness and acceptance amongst people about mental health. Amongst the regions, Asia Pacific accounts for the largest regional share in the global central nervous system therapeutic market in 2018.

Key factors driving the robust growth rate of Asia Pacific region include rising geriatric population along with increasing incidences of neurodegenerative diseases, increase in chronic ailments and growing per capita healthcare expenditure worldwide.

What are the major Central Nervous System Therapeutic segments covered in the Azoth Analytics report?

The major Central Nervous System Therapeutic segments covered in the report include Cancer, Neurovascular, Degenerative disorder, Mental Health, Trauma, Infection

What are the regions and countries covered in the study on Global Central nervous System Therapeutic Market?

The regional markets covered in the report include North America, Europe, APAC and Rest of the World.

The countries analyzed in the report include US, Canada, UK, Germany, China, Japan, India, Brazil

Name the companies profiled in the report?

The companies profiled in the report include Biogen, Pfizer, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Shire, Merc & Co, AstraZeneca, Otsuka Pharmaceutical, Eli Lilly

What are the key factors driving the market of Central Nervous System Therapeutic?

·         Increase in geriatric population along with increasing prevalence of neuro degenerativediseases

·         Product development and commercialization of serotonin supplements.

·         Improving medical infrastructure.

·         Growing expenditure on healthcare and advantageous reimbursement opportunities.